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Objectives. Risk of thrombo-embolic stroke is thought to be better reflected by carotid plaque composition than by luminal
stenosis. We set out to determine whether high resolution MRI was a valid method of quantifying plaque components in
vivo.
Design. A prospective cohort study validating in vivo MRI against histological analysis of excised carotid plaques.
Materials. Twenty-five recently symptomatic patients with severe internal carotid artery stenosis underwent pre-operative
in vivo multi-sequence MRI of the carotid artery using a 1.5 T system.
Methods. Individual plaque constituents were characterized on axial MR images according to net signal intensities.
Analysis of fibrous cap and lipid core content was quantified proportional to overall plaque area. Bland–Altman plots were
generated, and intra-class coefficients computed to determine the level of agreement between the two methods and inter-
observer variability.
Results. The intra-class correlation coefficients between two MR readers were 0.94 and 0.88 for quantifying fibrous cap and
lipid core components, respectively. There was good agreement between MR and histology derived quantification of both
fibrous cap and lipid core content; the mean % difference for fibrous cap was 0.75% (^2.86%) and for lipid core was 0.86%
(^1.76%).
Conclusion. High resolution carotid MRI can be used to quantify plaque components and may prove useful in risk
stratification.
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Introduction
Thrombo-embolism from extra-cranial atherosclerosis
accounts for the neurological deficit in approximately
half of people with ischaemic stroke.1,2 Selection for
disease eradicating interventions is conventionally
determined by measuring luminal stenosis that results
from in situ atheromatous plaques.3,4 These traditional
stratification parameters are no longer thought to be
the most accurate predictors of thrombo-embolism, as
the process of vessel wall remodeling can maintain
luminal patency,5 and consequently, very large friable
plaques may remain unidentified. Furthermore, natu-
ral history studies suggest that a large number of
patients with severe ICA stenosis are asymptomatic
and that the risk of subsequent thrombo-embolism in
this population is low.6,7 Histological studies of
coronary atherosclerosis suggest that plaques at risk
of rupture, so called vulnerable plaques, can be
identified by thin fibrous caps that overly large, often
necrotic lipid cores.8,9 The prospective identification of
vulnerable carotid plaques in vivo, may therefore
improve risk stratification and selection for interven-
tion. Recently, high resolution MRI has emerged as an
accurate non-invasive tool that is able to characterize
carotid plaque components in vivo.10,11 There are
limited reports of flow-suppressed MRI techniques to
measure overall lumen size and total plaque area as
surrogates for plaque burden.12 –14 These in vivo
studies have, however, lacked quantification of the
fibrous cap and lipid core components, the relative
amounts of which are thought to contribute directly to
plaque vulnerability.15 In the present study we set out
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to determine the potential of high resolution multi-
sequence MR imaging to quantify these plaque
components in human carotid arteries in vivo.
Materials and Methods
Patients
Approval for the study was obtained from the
Institutional ethics committee. Twenty-five consecu-
tive symptomatic patients with severe ICA stenosis (18
males; mean age 64, range 45–88 years; mean % ^ SD
stenosis ¼ 80 ^ 7.2; mean ^ SD temporal interval
from symptoms to surgery of 16.9 weeks ^ 7.1)
scheduled for carotid endarterectomy4 were recruited
from a specialist neurovascular clinic after giving
informed consent to participation. All patients under-
went high resolution multi-sequence MR imaging of
the carotid bifurcation pre-operatively.
MRI
Imaging studies were conducted on a 1.5 Twhole body
system (CV/i, GE Medical Systems, Milwaukee, WI,
USA) using a custom designed four-channel phased
array surface coil (Flick Engineering Solutions BV,
Winterswijk, The Netherlands) wrapped around the
neck, and secured by a soft cervical collar. Addition-
ally, patients were rested in foam head rest to
minimize motion artifacts. After an initial coronal
localizer scan, an axial 2D time of flight (ToF) MR
angiogram study was performed to identify the
location of the carotid bifurcation and region of
stenosis. Axial images were acquired through the
common carotid artery (CCA), 6 mm (two slices)
below the carotid bifurcation to a point 6 mm (two
slices) distal to the extent of the stenosis identified on
the ToF sequence. This method ensured that the entire
plaque was imaged and also facilitated image co-
registration (see below). The following 2D, ECG-gated,
blood-suppressed, fast spin echo pulse sequences
were used: intermediate T2W (TR/TE: 2*RR/46)
with fat saturation, T2W (TR/TE: 2*RR/100), short
T1 inversion-recovery (STIR) (TR/TE/TI:
2*RR/46/150), and T1W (TR/TE: 1*RR/ 7.8). The
pixel size was 0.39 £ 0.39 £ 3 mm3 in all cases. The
field of view was 10 cm and matrix size 256 £ 256.
Histological analysis
Atheromatous plaques were excised intact, to facilitate
the image co-registration, and immediately rinsed in
0.9% sodium chloride solution before fixation in 10%
formalin solution. Plaques were then cut into 3 mm
sections with reference to the start of the bifurcation
(often three sections below and up to six sections
above) following decalcification in ethylenediaminete-
traacetate (EDTA) solution, and embedded in paraffin
blocks. From these blocks 4 mm sections were obtained
from the caudal end. Sections were dehydrated and
underwent haematoxylin and eosin (H&E) and Elastic
van Gieson (EVG) stains to define the fibrous cap, lipid
core, calcium and haemorrhage components. The
fibrous cap stained positively on the EVG section.
The lipid core was identified by the area of necrotic
material within which residual cholesterol crystals
were seen on both H&E and EVG stains. Areas of
calcification did not stain on EVG but had a blue hue
from the haematoxylin in H&E sections, following the
decalcifying process. Plaque haemorrhage was
defined easily by the presence of fibrin and extra-
vasated blood on the H&E section.
Image co-registration
The location of axial MR images (3 mm thickness) in
relation to the carotid bifurcation was known from the
planning ToF images. These were matched to corre-
sponding histological sections from blocks located by
reference to the carotid bifurcation of the ex vivo
specimen, by two operators in consensus. Histological
sections were then visually co-registered for orien-
tation with the axial MR images. The process of image
co-registration with reference to anatomical markers
on MR and the ex vivo plaque resulted in little
difficulty in matching corresponding pairs.
Image analysis
Axial MR images and histological sections were
reviewed independently by experienced readers.
Only MR images on which the entire vessel border
was clearly visible and the lumen was free of flow
artifact on all position matched sequences, were
included in the image analysis. This initial image
selection process was conducted by an independent
operator not involved in the measurement analysis.
An earlier pilot study validated the signal intensities of
the individual plaque components on the different MR
sequences with histology.16 From this earlier analysis
the STIR sequence was determined to be the best to
identify the fibrous cap and lipid core components.
Any area of very high signal, adjacent to the lumen, on
the STIR sequence was classified as fibrous cap.
Haemorrhage infrequently gave similar appearance
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on this sequence but not the others therefore, the other
sequence images were viewed to confirm that the high
signal region on the STIR image was fibrous cap. Lipid
core was seen as a low signal region on the STIR
sequence but of intermediate intensity on the T1Wand
intermediate T2W sequences. These other sequences
were reviewed to ensure that the low signal region on
the STIR sequence was not calcium, as this can appear
as a low signal region on both T1 and T2 weighted
sequences. Following the initial characterization, only
the STIR images depicting plaques free of haemor-
rhage or calcium were used in the quantitative
component analysis.
Measurement analysis
Using the Analyze software (version 4; BIR, Mayo
Clinic, Rochester, MN, USA) axial MR images were
magnified 200% prior to localizing the carotid artery
region, to maximize measurement accuracy and
consistency. Image contrast settings were adjusted on
all images to achieve standardized window/level
settings. The following measurements were made
using a manual tracing technique: the area of the
fibrous cap (FC) and lipid core (LC) components and
total plaque (TPA). Only areas within the vessel that
the readers were confident to assign as fibrous cap or
lipid core, based on the above algorithm were defined
in the component analysis. The FC area was defined as
the region of high signal intensity enclosed between
the lumen and the low signal region below, by a
manually traced contour (Fig. 1(a)). The area of the LC
was defined as the region of low signal intensity (if
present) below the fibrous cap, enclosed by the
manually traced contour (Fig. 1(a)). The TPA was
defined as the region enclosed by the manually traced
contour, which included the fibrous cap and lipid core
components, as well as regions that were not con-
fidently assigned as either fibrous cap or lipid core.
The radial extent approximated the vessel boundary
and luminal edges (Fig. 1(a)); the vessel wall boundary
appeared of slightly higher signal intensity compared
to the surrounding tissue and was defined as the edge
beyond which the region was no longer considered to
be within the vessel but within the adjacent soft tissue.
An experienced reader independently reviewed
stained histological sections and identified the FC
and LC components and similar area measurements
(FC, LC and TPA) were made, again using a manual
tracing contour using computerized planimetry (Leica
Qwin, Milton Keynes, UK) from digitally captured
images using a 1.6 magnification lens which allowed
the entire vessel cross-section to be visualized in one
field of view (Fig. 1(b)). Measures of plaque burden
analysed ex vivo by others12 were not assessed in this
study as from the earlier characterization it was
evident that section deformation due to the relative
thin nature of non-diseased vessel wall (Fig. 1(b))
wouldmake assessment of both lumen and total vessel
area difficult on histological sections.
Statistical analysis
The relative proportion of the plaque made up by the
FC and LC components was quantified as a percentage
of TPA, so that the amount of FC and LC were defined
as the quotients of the cross-sectional area of FC and
LC, respectively, divided by the cross-sectional
TPA £ 100%. Inter-observer variability for measure-
ments taken by the two MR readers was determined
by computing the intra-class coefficient for both
components. For the comparative analyses with
histology, the mean values of the two MR measure-
ments were used. The level of agreement between MR
and histology based measurements for the component
quantification was determined by generating Bland–
Altman plots. All data were analyzed using SPSS for
Windows (version 9).
Results
One hundred and eleven corresponding MR images
and histological sections from 23 patients (average five
corresponding image pairs per patient; range 3–6)
were available for analysis. Corresponding MR and
histological images from two patients (11 slices/sec-
tions) were excluded because of poor image quality or
histological preparation. Seven sections from three
plaques contained haemorrhage (Fig. 2); there were a
Fig. 1. Corresponding (a) cross-sectional STIR sequence and
(b) histological section image matched by reference to the
carotid bifurcation, showing basis of area measurements of
fibrous cap (grey area) and lipid core (yellow area), and
delineation of total plaque area contour (red line).
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further 23 MR slices (from nine plaques) thought to
depict calcium (Fig. 3). These 30 corresponding MR
and histology pairs were excluded from the FC and LC
measurement analysis. Consequently FC and LC area
measurement analysis was performed on 81 corre-
sponding MR and histological pairs.
There was excellent inter-observer agreement
between MR readers for quantifying cross-sectional
fibrous cap and lipid core areas, with an intra-class
coefficient of 0.88 (95% confidence intervals: 0.73, 0.95)
for LC measurements, 0.94 (95% confidence intervals:
0.89, 0.97) for FC measurements. Histological analysis
revealed that the median fibrous cap content of
plaques was 60.11%, and that of the lipid core was
32.5% in those plaques that did not contain either
haemorrhage or calcium. The mean (^2 SD) difference
between MR and histology derived component
quantification was 20.87% (^1.76%) for LC and
20.75% (^2.86%) for FC. Bland–Altman plots
revealed strong agreement between MR and histology
derived quantification of both components (Figs. 4 and
5). The level of agreement between MR and histology
was stronger for quantifying fibrous cap content than
for lipid core content but for both components, 95% of
values were within two standard deviations of the
mean difference.
Discussion
Until recently assessment of carotid athero-thrombosis
following ischaemic stroke or transient ischaemic
attacks (TIA), has been confined to quantitative
assessment of luminal patency of the internal carotid
artery. However, only selected symptomatic patients
with severe stenosis have benefited from disease
eradicating surgery.3,4 Additionally asymptomatic
patients have been assessed by similar standards and
although as a group have been shown to benefit from
surgery, this has not been universally offered.17
Consequently, the current method of risk stratification
may not be sufficient enough to accurately identify the
high-risk patient. High-risk patients are thought to
harbour vulnerable plaques18 and these vulnerable
plaques can be visualized in a number of different
ways. Ultrasound techniques are able to distinguish
echolucent (predominant lipid core) from echo opaque
plaques (predominant fibrous tissue/calcium), but are
limited by resolution and are prone to inter-observer
variability.19–23 More recent reports, however, have
Fig. 2. Axial (a) T1W, (b) Intermediate T2Wand (c) STIR MR
images co-registered with (d) corresponding histological
section (stained with H&E) depicting low signal appearance
of calcium (yellow arrow) and high signal appearance of the
fibrous cap (red arrow).
Fig. 3. Corresponding STIR sequence MR image and
histological section, stained with H&E showing the high
signal appearance of recent haemorrhage (arrow).
Fig. 4. Bland–Altman analysis plot of MR and histology
derived fibrous cap content measurements. 95% of values lie
within 2 SD of the mean difference (20.75 ^ 2.86%).
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extended the repertoire of characterization with
promise of ultrasonographic correlates of cellular
plaque components.24,25 Several studies have demon-
strated the accuracy of multi-sequence high resolution
MRI to identify individual plaque components,10,26,27
and furthermore carotid MRI is able to monitor plaque
progression.28,29 Although some of these studies have
used surrogates of plaque burden, such as total vessel
wall thickness and relative size of lumen, there have
been no previous studies that have attempted to
quantify the individual plaque components. The latter
is of considerable importance, in terms of risk
stratification as histological studies have suggested
that the relative amounts of the individual plaque
components are important in determining plaque
vulnerability. In this study we have shown that both
the fibrous cap and lipid core components can be
quantified using multi-sequence high resolution MRI
with little inter-observer variability. For this validation
study we chose to quantify the fibrous cap and lipid
core components as an area percentage of total cross-
sectional plaque area as this was thought to provide a
better measure of burden than the absolute amount,
particularly as critical thresholds have not yet been
established for either of these plaque components.
Secondly, the process of specimen fixation would
cause plaque shrinkage and make comparison of the
absolute values futile. We would, however, expect the
area percentage determined by histology to still be
proportionately representative as the fixative process
causes shrinkage in the FC and LC components to
similar extents. A recent report further showed that
there is a considerable variation in the amount of
plaque shrinkage between ex vivo specimens from
different patients and so any relationship derived from
absolute component measurements would not necess-
arily be widely applicable to all patients.30 Although
we had little difficulty in identifying the fibrous cap
and lipid core on MR images using our algorithm, it
was more difficult to determine the full extent of either
component in the shoulder regions, especially of
eccentric shaped plaques and this might explain both
the spread of values and the consistent over estimation
of MR for the FC and LC area percentage measure-
ments, as histological analysis was not subject to the
same difficulties. We found that agreement between
MR and histology was stronger for FC measurements
than LC measurements, suggesting that the fibrous
cap was easier to distinguish and delineate than the
lipid core. It is, therefore, likely that with better tissue
characterization, the agreement between MRI and
histology for LC area measurements could potentially
be improved.
We accept that by only attempting to validate the FC
and LC burden with histology, the present MR study
has some limitations. Intra-plaque haemorrhage is
likely to alter the haemodynamic profile of plaques
and as such the relative amount of haemorrhage
would be an important parameter to quantify. Due to
the heterogeneity of MR appearance both within any
particular MR sequence series as well as between
different sequences, haemorrhage is not reliably
distinguishable. This most probably reflects the vary-
ing stages of haemoglobin degradation and conse-
quently its ferromagnetic nature. Studies undertaken
to determine the characterization of haemorrhage
have shown this was only reliably identified when
coupled with identification of the necrotic lipid core,
which has overlapping signal intensity character-
istics.11 The role that calcium plays in plaque stability
is also not fully established, with some authors
suggesting a protective role31,32 and others indicating
that calcified plaques may alter the haemodynamic
stress that the plaque can withstand, and may in fact
increase the risk of rupture.33 Calcium has a low signal
intensity appearance on T1Wand T2W sequences and
its presence is suggested by this fact. As the signal
intensity characteristics overlap with lipid as well as
haemorrhage on T2W sequences, MRI based charac-
terization is reliant on multi-sequence review. Conse-
quently, difficulties arise in MRI quantification when
either the lipid core itself is partially calcified or is
adjacent to an area of calcification. Plaque calcification,
however, is better identified with CT angiography,
where quantitative measurements are more reliable,34,
35 and consequently a combined MR/CT approach to
plaque characterization may overcome this problem.
It is likely that there exists a critical percentage area
Fig. 5. Bland–Altman analysis plot of MR and histology
derived lipid core content measurements. 95% of values lie
within 2 SD of the mean difference (20.86 ^ 1.74%).
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of FC below which and of LC above which, perhaps as
a result of haemodynamic stress, that risk of plaque
rupture is particularly high. The present study
included only recently symptomatic patients and as
such is not representative of the breadth of athero-
sclerotic plaques. Furthermore, as can be seen from the
histology derived quantification, that the plaques in
this study had a predominant fibrous cap content,
most akin to the advanced but ‘stable’ fibroatheroma
subtype described by the American Heart Associ-
ation8 and others.9 In order to determine whether
thresholds exist for the contribution of FC and LC to
plaque burden, larger prospective studies need to be
conducted, to include symptom free people with and
without cardiovascular risk factors, which might yield
a broader range of atherosclerotic plaques to include
early lesions.
We have demonstrated the validity of MR in plaque
quantification, and as such this technique has the
potential for prospective, longitudinal plaque charac-
terization and quantification studies in those asymp-
tomatic patients who are deemed at high risk of stroke,
as well as offering itself as a novel means to assess the
impact of various therapeutic interventions.
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